Robert Hutchison

Robert Hutchison serves as a Contract Specialist within the 262-NETWORK Contract Office 22 (36C262) of the Department of Veterans Affairs, where he plays a pivotal role in executing mission-critical procurements to sustain and modernize VA healthcare infrastructure. His responsibilities include managing the full lifecycle of acquisitions for in-vitro diagnostic substances and related medical technologies, ensuring compliance with federal contracting regulations while aligning purchases with clinical operational readiness goals. He routinely handles complex sole-source and competitive solicitations for high-precision diagnostic manufacturing and specialized medical supply chain services essential to veteran care delivery across VA medical centers. Hutchison maintains established working relationships with key industry partners including EXELAN PHARMACEUTICALS INC, SIRTEX MEDICAL INC, ONE LIFE TRANSPORTATION LLC, SCIENCE APPLICATIONS INTERNATIONAL CORPORATION, and SJS EXECUTIVES, LLC. These contractors provide specialized diagnostic reagents, targeted radionuclide therapies, medical logistics, and technical support services critical to VA’s clinical capabilities. His procurement approach emphasizes technical rigor, regulatory compliance, and long-term vendor performance, fostering reliable partnerships with firms possessing deep domain expertise in diagnostic manufacturing and healthcare logistics. Hutchison’s contracting portfolio reflects a 100% preference for non-set-aside acquisitions, indicating a focus on technical specificity and mission-critical performance over socioeconomic categorization. While small business participation is not formally prioritized in his award patterns, his selections are driven by the necessity for validated, FDA-compliant manufacturing capabilities and proven reliability in high-stakes medical environments. His primary procurement focus is centered on NAICS 325413—In-Vitro Diagnostic Substance Manufacturing—where he secures specialized reagents, assay kits, and diagnostic materials used in clinical laboratories supporting veteran health outcomes. His expertise lies in navigating the regulatory and technical complexities of diagnostic product procurement, ensuring that all acquisitions meet stringent FDA and VA clinical standards for accuracy, safety, and scalability.